Perivalvular Leakage: Percutaneous Treatment Options
Fig. 11.1 “Clock face” orientation of the mitral prosthesis as seen from the left atrial “surgical” approach. Twelve o’clock corresponds to the junction with the aortic valve, while 9 o’clock…
Difficult Cases and Complications from the Catheterization Laboratory: A Case of Nitinol Intolerance
(1) David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA 90095, USA Jonathan M. Tobis Email: jtobis@mednet.ucla.edu 24.1 Introduction Patent foramen ovale (PFO) affects up to 20…
Difficult Cases and Complications from the Catheterization Laboratory: A Case of Platypnea-Orthodeoxia Syndrome
Fig 23.1 AP projection. Two prostheses are delivered across PFO. The second is positioned behind the first one and acts as a “staple” of the two disks of the first…
Difficult Cases and Complications from the Catheterization Laboratory: PFO Device Embolization and Settling in the Distal Aorta
Fig. 22.1 Panel (a) balloon sizing the persistent foramen ovale (PFO) at the first procedure. The waist on the balloon (arrow) is situated at the defect and was used to…
Current and Next Generation of Transcatheter Valves
Fig. 8.1 New valves currently available for clinical use. Currently available and underdevelopment transcatheter valves (a) Medtronic Evolut (Medtronic Inc, Minneapolis, MN), USA). (b) Sapien 3 (Edwards Lifesciences, Irvine, CA,…
Difficult Cases and Complications from the Catheterization Laboratory: Case 3 “The Importance of Being Prepared”
Fig. 7.1 Preoperative multimodality imaging evaluation of access site. Extensive circumferential calcification of the iliac-femoral arterial tree at multidetector computed tomography (panel A, B). No significant stenosis is documented at…
Percutaneous Left Atrial Appendage Closure: Rational, Patient Selection, and Preoperative Evaluation
Risk factors Points C Congestive heart failure (or left ventricular ejection fraction <40 %) 1 H Hypertension: blood pressure above 140/90 mmHg or treatment 1 A2 Age ≥75 years…
Percutaneous Options, Patient Selection, and Preoperative Evaluation
Author Year No. of patients Findings Mugge [19] 1995 195 Patients with ASA and shunt showed a high frequency of previous clinical events (65 %) Bogousslavsky [20] 1996 140 The…
Severe Mitral Regurgitation Treatment: Percutaneous Options, Patient Selection, and Preoperative Evaluation
Fig. 9.1 Mitral apparatus. In bold the anatomical targets of the current commercially available percutaneous devices (Modified with permission from Asgar et al. [5]) Each of these components represents a…
Severe Aortic Stenosis Treatment: Percutaneous Options, Patient Selection, and Preoperative Evaluation
Fig. 1.1 The collaborative approach of the Heart Team allows accurate evaluation of the risk/benefit ratio of either surgical AVR, TAVI, BAV, or medical therapy. AS aortic stenosis, AVR aortic…
